Rayence Co

Rayence Co Pre-Tax Margin

The Pre-Tax Profit Margin of Rayence Co (228850.KQ) as of Nov 7, 2026 is -3.21 %. In the previous year, Pre-Tax Profit Margin was 9.72 % — a change of -133.00% (lower).

Pre-Tax Margin

-3.21 %

YoY

-133.00%

Last updated:

Pre-Tax Profit Margin of Rayence Co is 2025 -3.21 % . Pre-Tax Profit Margin of Rayence Co was 2024 9.72 % . It decreases by -133.00% lower compared to the previous year.

The Rayence Co Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2018
18.77 KRW
Jan 1, 2019
16.67 KRW
Jan 1, 2020
-1.99 KRW
Jan 1, 2021
15.10 KRW
Jan 1, 2022
17.17 KRW
Jan 1, 2023
16.45 KRW
Jan 1, 2024
9.72 KRW
Jan 1, 2025
-3.21 KRW
The Rayence Co Pre-Tax Margin history
YEARPre-Tax MarginYoY
-3.21 %-133.00%
9.72 %-40.94%
16.45 %-4.15%
17.17 %+13.70%
15.10 %-859.55%
-1.99 %-111.93%
16.67 %-11.23%
18.77 %+34.41%
13.97 %-23.16%
18.18 %-12.19%
20.70 %+294.75%
5.24 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Pre-Tax Profit Margin of Rayence Co is -3.21 % in 2025.

Pre-Tax Profit Margin of Rayence Co changed from 9.72 % to -3.21 %, representing a -133.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Rayence Co since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Rayence Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Rayence Co

All Key Metrics — Rayence Co